Search

Downloadable resources

The WHO has produced a number of handbooks and guidelines that are used by the LF programmes within countries and at CNTD to ensure that all the activities are conducted to the global standard and reported in the manner. It is recommended that these documents, found on the WHO Publication website, be reviewed by all programme staff prior to the planning of any activity.

The following handbooks and manuals are recommended for use by all programme staff:

World Health Organization. (2000). Operational Guidelines for Rapid Mapping of Bancroftian Filariasis in Africa.
To be referenced regarding mapping of LF in Africa.

World Health Organization. (2006). Preventive chemotherapy in human helminthiasis
To be referred to regarding the planning and implementation of MDA/PCT for LF or any other PCT diseases. 

World Health Organization. (2010). Monitoring Drug Coverage for Preventive Chemotherapy. To be referred to regarding the monitoring of reported and surveyed drug coverage that takes place after MDA/PCT.

World Health Organization. (2011). WHO/GPELF Monitoring and Epidemiological Assessment of Mass Drug Administration
This handbook should be referred to regarding any and all monitoring and evaluation activities that will be taking place in country. This ranges from mapping to monitoring coverage thru to the transmission assessment surveys and the diagnostic tools required at each step.

World Health Organization. (2012). Provisional strategy for interrupting lymphatic filariasis transmission in loiasis-endemic countries: Report of the meeting on lymphatic filariasis, malaria and integrated vector management.
This handbook outlines the provisional strategy for conducting LF MDA in regions where loiasis is endemic as the normal MDA strategy DOES NOT work.

 World Health Organization. (2013). WHO/GPELF Lymphatic Filariasis Practical Entomology. With the growing trend in IVM and its importance on the elimination of LF this manual should be kept in mind by all programme staff.

World Health Organization. (2013). WHO/GPELF Managing Morbidity and Preventing Disability.With the growing need of MMPD programmes in countries is crucial that all staff take the guidelines that are outlined in this handbook and implement them in country. The current WHO policy states that a country cannot be certified as LF free until all individuals have access to health care for LF morbidity within their country.

World Health Organization. (2013). WHO/GPELF Training in Monitoring and Epidemiological Assessment of MDA for Eliminating Lymphatic Filariasis - Facilitators’ Guide.
This manual goes in part with the learners’ guide to help train programme staff (in country and supporting organizations) how to conduct a transmission assessment survey from the facilitators’ perspective.

World Health Organization. (2013). WHO/GPELF Training in Monitoring and Epidemiological Assessment of MDA for Eliminating Lymphatic Filariasis - Learners’ Guide
This manual goes in part with the facilitators’ guide to help train programme staff (in country and supporting organizations) how to conduct a transmission assessment survey from the learners’ perspective.